Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -466.11x is 1209% below its 4-year average of -35.62x, near the low end of its 4-year range (-466.11x–398.86x).
As of the fiscal period ended Thursday, June 30, 2022. 841.04% below its 12-month average of -49.53x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2022 (2022-06-30): -466.11x.
INTEREST COVERAGE RATIO
-466.11x
INTEREST COVERAGE RATIO AVG TTM
-49.53x
INTEREST COVERAGE RATIO AVG 3Y
-44.52x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-841.04%
CURRENT VS 3Y AVG
-946.87%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.45x
median of 447 covered companies
CURRENT VS SECTOR MEDIAN
-8452.50%
vs the sector median at left
Lipocine Inc.
Market Cap
$17.15M
Interest Coverage Ratio
-466.11x
TTM Avg
-49.53x
3Y Avg
-44.52x
5Y Avg
N/A
Market Cap
$17.01M
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$17.48M
Interest Coverage Ratio
-6.31x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$16.73M
Interest Coverage Ratio
-1288.77x
TTM Avg
51.73x
3Y Avg
51.73x
5Y Avg
51.73x
Market Cap
$16.64M
Interest Coverage Ratio
-111.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.40M
Interest Coverage Ratio
-15.67x
TTM Avg
0.81x
3Y Avg
0.81x
5Y Avg
0.81x
Market Cap
$15.83M
Interest Coverage Ratio
-68.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lipocine Inc. (LPCN) | $17.15M | -466.11x | -49.53x | -44.52x | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | N/A | 1.00x | 1.00x | 1.00x |
| PAVmed Inc. (PAVM)vs › | $17.36M | -1038.38x | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.48M | -6.31x | 0.97x | 0.97x | 0.97x |
| Palatin Technologies, Inc. (PTN)vs › | $16.73M | -1288.77x | 51.73x | 51.73x | 51.73x |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -111.88x | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | -15.67x | 0.81x | 0.81x | 0.81x |
| BioCardia, Inc. (BCDA)vs › | $16.22M | N/A | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.83M | -68.14x | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.86M | N/A | N/A | N/A | N/A |
Interest Coverage
-466.1x
Debt/Equity
0.00
Current Ratio
11.48
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-06-30 | -466.11x |
| 2021-12-31 | 398.86x |
| 2021-09-30 | -78.81x |
| 2021-06-30 | -52.07x |
| 2021-03-31 | -45.16x |
| 2020-12-31 | -59.18x |
| 2020-09-30 | -51.90x |
| 2020-06-30 | -48.07x |
| 2020-03-31 | -34.47x |
| 2019-12-31 | -42.99x |
| 2019-09-30 | -16.22x |
| 2019-06-30 | -16.38x |
| 2019-03-31 | -13.97x |
| 2018-09-30 | -10.77x |
| 2018-06-30 | -14.96x |
| 2018-03-31 | -13.70x |
